- Lenalidomide, sold
under the
brand name
Revlimid among others, is a
medication used to
treat multiple myeloma,
smoldering myeloma, and myelodysplastic...
-
pharmaceutical company that
makes cancer and
immunology drugs. Its
major product is
Revlimid (lenalidomide),
which is used in the
treatment of
multiple myeloma, and...
-
Chlorantraniliprole (CTPR)
based products.
NATCO launched the
first generic version of
Revlimid in the US
market For the
financial Year 2024,
NATCO recorded its highest...
-
Clinic during early April 2006. He parti****ted in a
study of the drug
Revlimid,
which had been
approved recently for
multiple myeloma but not yet tested...
-
generic drug names, e.g., VRd for
Velcade (brand name for bortezomib),
Revlimid (brand name for lenalidomide) and dexamethasone.
Similarly with DKRd, with...
-
Celgene received FDA
approval for
lenalidomide (
Revlimid) as the
first commercially useful derivative.
Revlimid is
available only in a
restricted distribution...
- Celgene's
operations in
China as well as the
rights to
commercialize Abraxane,
Revlimid and Vidaza, Celgene's
approved drugs in China. As part of the deal, Celgene...
-
apixaban anticoagulant Eliquis 9872 7395 4
lenalidomide multiple myeloma Revlimid 9685 8187 5
nivolumab oncology Opdivo 7570 5763 6
pembrolizumab oncology...
-
Retrieved 15
August 2014. "Phase III
FIRST (MM-020/IFM 07-01)
trial of
REVLIMID (lenalidomide) plus
dexamethasone in
newly diagnosed multiple myeloma patients...
-
Retrieved 2011-01-02. "Myeloma
Canada calls on
Quebec government to
approve Revlimid as second-line therapy". News-medical.net. 2010-02-26.
Retrieved 2011-01-02...
